BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17334980)

  • 1. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
    Ströbel P; Murumägi A; Klein R; Luster M; Lahti M; Krohn K; Schalke B; Nix W; Gold R; Rieckmann P; Toyka K; Burek C; Rosenwald A; Müller-Hermelink HK; Pujoll-Borrell R; Meager A; Willcox N; Peterson P; Marx A
    J Pathol; 2007 Apr; 211(5):563-571. PubMed ID: 17334980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
    Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
    J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
    Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas.
    Scarpino S; Di Napoli A; Stoppacciaro A; Antonelli M; Pilozzi E; Chiarle R; Palestro G; Marino M; Facciolo F; Rendina EA; Webster KE; Kinkel SA; Scott HS; Ruco L
    Clin Exp Immunol; 2007 Sep; 149(3):504-12. PubMed ID: 17590173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoma and paraneoplastic myasthenia gravis.
    Marx A; Willcox N; Leite MI; Chuang WY; Schalke B; Nix W; Ströbel P
    Autoimmunity; 2010 Aug; 43(5-6):413-27. PubMed ID: 20380583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups.
    Hapnes L; Willcox N; Oftedal BE; Owe JF; Gilhus NE; Meager A; Husebye ES; Wolff AS
    J Clin Immunol; 2012 Apr; 32(2):230-7. PubMed ID: 22127461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes.
    Meager A; Peterson P; Willcox N
    Clin Exp Immunol; 2008 Oct; 154(1):141-51. PubMed ID: 18727623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice.
    Kärner J; Meager A; Laan M; Maslovskaja J; Pihlap M; Remm A; Juronen E; Wolff AS; Husebye ES; Podkrajšek KT; Bratanic N; Battelino T; Willcox N; Peterson P; Kisand K
    Clin Exp Immunol; 2013 Mar; 171(3):263-72. PubMed ID: 23379432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIRE deficiency, from preclinical models to human APECED disease.
    Besnard M; Padonou F; Provin N; Giraud M; Guillonneau C
    Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33729987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
    Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
    J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications.
    Kisand K; Lilic D; Casanova JL; Peterson P; Meager A; Willcox N
    Eur J Immunol; 2011 Jun; 41(6):1517-27. PubMed ID: 21574164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
    Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
    Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-interferon auto-antibodies in autoimmune polyendocrinopathy syndrome type 1.
    Levin M
    PLoS Med; 2006 Jul; 3(7):e292. PubMed ID: 16756392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice.
    Kuroda N; Mitani T; Takeda N; Ishimaru N; Arakaki R; Hayashi Y; Bando Y; Izumi K; Takahashi T; Nomura T; Sakaguchi S; Ueno T; Takahama Y; Uchida D; Sun S; Kajiura F; Mouri Y; Han H; Matsushima A; Yamada G; Matsumoto M
    J Immunol; 2005 Feb; 174(4):1862-70. PubMed ID: 15699112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIRE expression controls the peripheral selection of autoreactive B cells.
    Sng J; Ayoglu B; Chen JW; Schickel JN; Ferre EMN; Glauzy S; Romberg N; Hoenig M; Cunningham-Rundles C; Utz PJ; Lionakis MS; Meffre E
    Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 30979797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
    Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
    Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projection of an immunological self shadow within the thymus by the aire protein.
    Anderson MS; Venanzi ES; Klein L; Chen Z; Berzins SP; Turley SJ; von Boehmer H; Bronson R; Dierich A; Benoist C; Mathis D
    Science; 2002 Nov; 298(5597):1395-401. PubMed ID: 12376594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond.
    Marx A; Hohenberger P; Hoffmann H; Pfannschmidt J; Schnabel P; Hofmann HS; Wiebe K; Schalke B; Nix W; Gold R; Willcox N; Peterson P; Ströbel P
    J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S266-72. PubMed ID: 20859117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG.
    Suzuki E; Kobayashi Y; Yano M; Fujii Y
    Autoimmunity; 2008 Aug; 41(5):377-82. PubMed ID: 18568643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.